|
Publications
Human Immunodeficiency Virus (HIV)
Ho J, MacDonald KS, Barber BH. Construction
of recombinant targeting immunogens incorporating an HIV-1 neutralizing
epitope into sites of differing conformational constraint.
Vaccine. 2002 Jan 15;20(7-8):1169-80.
Lei B, DeLeo FR, Hoe NP, Graham MR, Mackie SM, Cole
RL, Liu M, Hill HR, Low DE, Federle MJ, Scott JR, Musser JM. Evasion
of human innate and acquired immunity by a bacterial homolog of
CD11b that inhibits opsonophagocytosis. Nat Med. 2001
Dec;7(12):1298-305.
Ostrowski MA, Gu JX, Kovacs C, Freedman J, Luscher MA,
MacDonald KS. Quantitative and qualitative assessment
of human immunodeficiency virus type 1 (HIV-1)-specific CD4+ T
cell immunity to gag in HIV-1-infected individuals with differential
disease progression: reciprocal interferon-gamma and interleukin-10
responses. J Infect Dis. 2001 Nov 15;184(10):1268-78.
MacDonald KS, Matukas L, Embree JE, Fowke K, Kimani
J, Nagelkerke NJ, Oyugi J, Kiama P, Kaul R, Luscher MA, Rowland-Jones
S, Ndinya-Achola J, Ngugi E, Bwayo JJ, Plummer FA. Human
leucocyte antigen supertypes and immune susceptibility to HIV-1,
implications for vaccine design. Immunol Lett. 2001 Nov
1;79(1-2):151-7.
Kaul R, Rowland-Jones SL, Kimani J, Fowke K, Dong T,
Kiama P, Rutherford J, Njagi E, Mwangi F, Rostron T, Onyango J,
Oyugi J, MacDonald KS, Bwayo JJ, Plummer FA. New insights
into HIV-1 specific cytotoxic T-lymphocyte responses in exposed,
persistently seronegative Kenyan sex workers. Immunol
Lett. 2001 Nov 1;79(1-2):3-13.
Caillot D, Bassaris H, McGeer A, Arthur C, Prentice
HG, Seifert W, De Beule K. Intravenous itraconazole followed
by oral itraconazole in the treatment of invasive pulmonary aspergillosis
in patients with hematologic malignancies, chronic granulomatous
disease, or AIDS. Clin Infect Dis. 2001 Oct 15;33(8):e83-90.
Dela Cruz C. S., Chamberlain J., MacDonald K. S., Barber
B. H., Xenogenic and Allogenic Anti-MHC Immune Responses
Induced by Plasmid DNA Immunization. Vaccine 17, 2479-2492.
1999.
Rowland-Jones, S. L., Dong, T., Dorrell, L., Ogg, G.,
Hansasuta, P., Krausa, P., Kimani, J., Sabally, S., Ariyoshi,
K., Oyugi, J., MacDonald, K. S., Bwayo, J., Whittle, H., Plummer,
F. A., and McMichael, A. J. Broadly cross-reactive HIV-specific
cytotoxic T-lymphocytes in highly- exposed persistently seronegative.
Immunol.Lett. 66[1-3], 9-14. 1999.
Kaul, R., Trabattoni, D., Bwayo, J. J., Arienti, D.,
Zagliani, A., Mwangi, F. M., Kariuki, C., Ngugi, E. N., MacDonald,
K. S., Ball, T. B., Clerici, M., and Plummer, F. A. HIV-1-specific
mucosal IgA in a cohort of HIV-1-resistant Kenyan sex workers.
AIDS 13[1], 23-29. 1-14-1999.
Luscher, M. A., Choy, G., Njagi, E., Bwayo, J. J., Anzala,
A. O., Ndinya-Achola, J. O., Ball, T. B., Wade, J. A., Plummer,
F. A., Barber, B. H., and MacDonald, K. S. Naturally occurring
IgG anti-HLA alloantibody does not correlate with HIV type 1 resistance
in Nairobi prostitutes. AIDS Res.Hum.Retroviruses 14[2],
109-115. 1-20-1998.
Check out out ARCHIVES for even
more publications
|
K. S. Macdonald, J. Castillo, J. Embree, S. Njenga,
J. D. Nagelkerke Nicolas, I. Ngatia, Z. Mohammed. Class
I MHC polymorphism and mother to child HIV-1 transmission in Kenya.
12th WORLD AIDS CONFERENCE, Geneva, Switzerland, June
28-July 3, 1998.
R. Kaul, D. Trabattoni, J. J. Bwayo, D. Arienti, M.
Clerici, F. A. Plummer. HIV-1 specific mucosal IgA in
a cohort of HIV-1 resistant Kenyan prostitutes. 12th
WORLD AIDS CONFERENCE, Geneva, Switzerland, June 28-July 3, 1998.
|
|
©Copyright 1999 Last Modified
|
|